These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3589176)

  • 41. Accidental coadministration of intravenous aminophylline and theophylline by mouth: a hazardous practice.
    Frewin DB; Cooper DJ
    Med J Aust; 1986 Apr; 144(9):481-2. PubMed ID: 3702795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 43. Aminophilline suppress the release of chemical mediators in treatment of acute asthma.
    Nakano J; Yano T; Yamamura K; Yoshihara H; Ohbayashi O; Yamashita N; Ohta K
    Respir Med; 2006 Mar; 100(3):542-50. PubMed ID: 16337368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    Freitag A
    Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epinephrine-aminophylline-induced arrhythmias after midazolam or thiopentone in halothane-anaesthetized dogs.
    Lina AA; Dauchot PJ; Anton AH
    Can J Anaesth; 1991 Nov; 38(8):1037-42. PubMed ID: 1752005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma potassium in acute severe asthma before and after treatment.
    Khan MA
    Br J Clin Pract; 1989 Oct; 43(10):363-5. PubMed ID: 2629946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease.
    Seidenfeld JJ; Jones WN; Moss RE; Tremper J
    Ann Emerg Med; 1984 Apr; 13(4):248-52. PubMed ID: 6367554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography.
    Matthay RA; Berger HJ; Loke J; Gottschalk A; Zaret BL
    Am J Med; 1978 Dec; 65(6):903-10. PubMed ID: 742629
    [No Abstract]   [Full Text] [Related]  

  • 50. [Salbutamol therapy of chronic bronchopathic patients with cardiac arrhythmias].
    Del Torre L; Fiore G; Macluso S; Pesce L
    Torace; 1976 Jan; 18(1-2):40-51. PubMed ID: 996855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunction.
    Rotstein Z; Battler A; Rath S; Perek J; Eldar M
    Clin Cardiol; 1990 Jul; 13(7):468-72. PubMed ID: 2364580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
    Grambau GR; Johnson CE; Conlon PF; Weg JG
    J Clin Pharmacol; 1985; 25(5):381-3. PubMed ID: 4031115
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 54. Cardiac dysrhythmias during the treatment of acute asthma. A comparison of two treatment regimens by a double blind protocol.
    Josephson GW; Kennedy HL; MacKenzie EJ; Gibson G
    Chest; 1980 Sep; 78(3):429-35. PubMed ID: 7418461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Favorable cardiovascular effects of theophylline in COPD.
    Matthay RA
    Chest; 1987 Jul; 92(1 Suppl):22S-26S. PubMed ID: 3297523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arrhythmias during combined procaterol-aminophylline treatment. A review of the literature and a personal series with dynamic electrocardiography.
    Galietti F; Giorgis GE; Miravalle C; Oliaro A; Ardizzi A; Barberis S
    Panminerva Med; 1988; 30(3):173-6. PubMed ID: 2974938
    [No Abstract]   [Full Text] [Related]  

  • 57. Aminophylline blood levels with concomitant erythromycin therapy in relapsed chronic obstructive lung disease.
    Vercelloni M; Cogo R; Albertini A; Granata M; Rosaschino F
    J Int Med Res; 1986; 14(3):131-6. PubMed ID: 3721053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bronchodilator effects on gastric acid secretion.
    Foster LJ; Trudeau WL; Goldman AL
    JAMA; 1979 Jun; 241(24):2613-5. PubMed ID: 439357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.